Key Highlights
- BPGbio appoints John Beeler, Ph.D., as Senior VP of Business Development
- Dr. Beeler brings over 20 years of experience in biotechnology and business development
- Will lead licensing and partnership efforts for BPGbio’s AI-developed therapeutic candidates
- Formerly served as Business Development Search & Evaluation Lead at Bristol-Myers Squibb
Source: Business Wire
Notable Quotes
- “Dr. Beeler’s deep industry knowledge and business development prowess will power BPGbio’s next phase of commercial growth as we continue to advance our pipeline and build impactful licensing deals and platform partnerships.” — Daniel Elliott, Executive Chairman at BPGbio
- “BPGbio’s unique biology-first approach, coupled with its proprietary NAi platform, has led to the development of several highly effective assets… I’m excited to share BPGbio’s remarkable achievements with potential partners.” — John Beeler, Ph.D., Senior VP at BPGbio
SoHC's Take
BPGbio’s strategic appointment of John Beeler reflects the company’s commitment to expanding its commercial reach and furthering its leadership in AI-driven biopharmaceuticals. Beeler’s extensive experience in business development and partnerships, particularly with top-tier companies like Bristol-Myers Squibb, positions BPGbio to capitalize on lucrative licensing opportunities and drive its robust pipeline of therapeutics forward. His leadership will likely accelerate BPGbio’s mission to bring transformative solutions to patients in critical areas such as oncology, rare diseases, and neurology.
Heading
Key Highlights CalmWave closes a $5.25M financing round led by Third Prime with contributions from Catalyst by Wellstar, Silver Circle, and ...
Key Highlights Alice Koehler appointed Managing Director of OMRON Healthcare North America. Koehler brings 25+ years of global experience in ...
Key Highlights Koda Health introduces Kidney Action Planning to support Chronic Kidney Disease (CKD) management with cutting-edge tools. Features include gamified patient ...
Key Highlights Northwell Health’s Aging Revolution Summit will take place virtually and in-person in NYC on December 3, 2024. Key themes: Therapeutics, ...
Key Highlights $5M Series A funding led by Empactful Capital to fuel growth and innovation. Investment will support product development, strategic accounts, and new market ...
Key Highlights New Lantern raises $19M Series A funding, led by Benchmark, totaling $23M raised to date. Platform automates 25% of ...
